Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 510, pseudogene (RN7SL510P) is a non-functional RNA gene derived from 7SL RNA, which itself is an essential component of the signal recognition particle (SRP) complex involved in guiding nascent secretory proteins to the endoplasmic reticulum. Unlike coding 7SL RNA genes, the RN7SL510P pseudogene does not produce a functional RNA and is not known to be expressed or involved in physiological processes. These pseudogenes are common in the human genome as dispersed, truncated copies of 7SL RNA, generally lacking biological function. Current evidence indicates that 7SL pseudogenes like RN7SL510P are not therapeutic targets, do not participate in signal transduction or other canonical pathways, and are not relevant as biomarkers, drug targets, or disease genes[1][9][10]. RN7SL510P may be referenced in genomic studies as part of the background of pseudogene content, but has no established therapeutic, diagnostic, or mechanistic relevance. --- **Notes and rationale:** - This entry is **not a therapeutic target**: it is a pseudogene, not an active receptor, enzyme, or protein[1][10]. - There is **no evidence for involvement in disease or drug interaction** for this specific pseudogene[1][10]. - "Is_incorrect" is set to true: your query references a pseudogene, which is not considered a typical "target molecule/receptor" for drug or biomarker discovery. - General information about 7SL RNA is included for context; however, the pseudogene does not perform these functions[5][9]. - If you need information on the **functional 7SL RNA (non-pseudogene)**, that would have distinct properties and some biological roles[5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 510, pseudogene (RN7SL510P).